Desq Long
Sign in

Company

CRISPR Therapeutics AG

CRSP · CIK 0001674416

SEC FORM 4
$2,381,325.86

CRISPR Therapeutics AG (CRSP)

Sale of 47,837 shares at $49.78 per share.

Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001193125-26-426878 · filed 2026-10-20 · View filing →

SEC FORM 4
—

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 100,000 shares; price not stated (see filing).

Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code M

Traded Oct 16, 2026 · Disclosed Oct 20, 2026

Source: SEC Form 4 · 0001193125-26-426878 · filed 2026-10-20 · View filing →

SEC FORM 4
$420,000.00

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 30,000 shares at $14 per share.

Reporting Person George Simeon · Transaction Code M

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001193125-26-424317 · filed 2026-10-16 · View filing →

SEC FORM 4
$720,373.36

CRISPR Therapeutics AG (CRSP)

Sale of 14,514 shares at $49.6330 per share.

Reporting Person George Simeon · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001193125-26-424317 · filed 2026-10-16 · View filing →

SEC FORM 4
$201,867.48

CRISPR Therapeutics AG (CRSP)

Sale of 4,098 shares at $49.26 per share.

Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001193125-26-423056 · filed 2026-10-15 · View filing →

SEC FORM 4
$51,230.40

CRISPR Therapeutics AG (CRSP)

Sale of 1,040 shares at $49.26 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001193125-26-423057 · filed 2026-10-15 · View filing →

SEC FORM 4
—

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 8,333 shares; price not stated (see filing).

Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code M

Traded Oct 13, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001193125-26-423056 · filed 2026-10-15 · View filing →

SEC FORM 4
—

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 2,113 shares; price not stated (see filing).

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code M

Traded Oct 13, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001193125-26-423057 · filed 2026-10-15 · View filing →

SEC FORM 4
$27,103.80

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 1,990 shares at $13.62 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code M

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001193125-26-418101 · filed 2026-10-08 · View filing →

SEC FORM 4
$119,481.19

CRISPR Therapeutics AG (CRSP)

Sale of 1,990 shares at $60.0408 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code S

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001193125-26-418101 · filed 2026-10-08 · View filing →

SEC FORM 4
$141,648.00

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 10,400 shares at $13.62 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code M

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401237 · filed 2026-09-24 · View filing →

SEC FORM 4
$626,459.60

CRISPR Therapeutics AG (CRSP)

Sale of 10,400 shares at $60.2365 per share.

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401237 · filed 2026-09-24 · View filing →

SEC FORM 4
$420,000.00

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 30,000 shares at $14 per share.

Reporting Person Behbahani Ali · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396944 · filed 2026-09-21 · View filing →

SEC FORM 4
$780,935.48

CRISPR Therapeutics AG (CRSP)

Sale of 13,679 shares at $57.0901 per share.

Reporting Person Behbahani Ali · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396944 · filed 2026-09-21 · View filing →